Showing results (31-40 of 1,827) with videos related to

Sort By:
Pageof 183
ESMO Open|April 11, 2022
Results from the INMUNOSUN-SOGUG trial: a prospective phase II study of sunitinib as a second-line therapy in patients with metastatic renal cell carcinoma after immune checkpoint-based combination therapyE Grande, T Alonso-Gordoa, O Reig, et al.
ESMO Open|April 10, 2022
Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trialsD König, S Schär, D Vuong, et al.
ESMO Open|April 2, 2022
Cancer-related fatigue and depression: a monocentric, prospective, cross-sectional study in advanced solid tumorsR Lobefaro, S Rota, L Porcu, et al.
ESMO Open|March 6, 2022
MRI-based contrast clearance analysis shows high differentiation accuracy between radiation-induced reactions and progressive disease after cranial radiotherapyR Bodensohn, R Forbrig, S Quach, et al.
ESMO Open|March 10, 2022
How I treat HER2-positive early breast cancer: how long adjuvant trastuzumab is needed?S Morganti, G Bianchini, A Giordano, et al.
ESMO Open|March 10, 2022
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinomaM Laganà, S Grisanti, R Ambrosini, et al.
ESMO Open|June 25, 2019
New emerging targets in cancer immunotherapy: the role of LAG3Hannah Christina Puhr, Aysegül Ilhan-Mutlu
ESMO Open|June 25, 2019
Assessing molecular subtypes of gastric cancer: microsatellite unstable and Epstein-Barr virus subtypes. Methods for detection and clinical and pathological implicationsCarolina Martinez-Ciarpaglini, Tania Fleitas-Kanonnikoff, Valentina Gambardella, et al.
ESMO Open|August 11, 2018
Phase I, open-label study of pasireotide in patients with BRAF-wild type and NRAS-wild type, unresectable and/or metastatic melanomaReinhard Dummer, Olivier Michielin, Mirjam Chantal Nägeli, et al.
ESMO Open|January 1, 2026
Immune checkpoint blockade in locally advanced rectal cancer with deficient DNA mismatch repair: retrospective multicenter experienceO E Emiloju, N R Foster, P Shah, et al.
Pageof 183